Strengthening screening for infectious diseases and vaccination among migrants in Europe: What is needed to close the implementation gaps?
Noori, T., Hargreaves, S., Greenaway, C., van der Werf, M., Driedger, M., Morton, R.L., Hui, C., Requena-Mendez, A., Agbata, E., Myran, D.T., Pareek, M., Campos-Matos, I., Nielsen, R.T., Semenza, J., Nellums, L.B., Pottie, K.
Prevention of hepatitis B and C in the EU/EEA and the UK
Urgent action is required to improve efforts to prevent hepatitis B and C infections in the EU/EEA and the UK if the region is to meet the 2020 targets for the elimination of viral hepatitis as a serious threat to public health. Significant gaps in the reported data in relation to prevalence and prevention of HBV and HCV in EU/EEA and the UK present a major challenge to monitoring progress towards the targets for elimination of hepatitis.
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
Maticic, M., Pirnat, Z., Leicht, A., Zimmermann, R., Windelinck, T., Jauffret-Roustide, M., Duffell, E., Tammi, T., Schatz, E.
Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action
Nakitanda, A.O., Montanari, L., Tavoschi, L., Mozalevskis, A., Duffell, E.
Hospital discharges of hepatocellular carcinoma and non-alcohol related cirrhosis in the EU/EEA and United Kingdom: a descriptive analysis of 2004–2015 data
Nakitanda, A.O., Duffell, E.
Prevalence of hepatitis C in the adult population of Bulgaria: A pilot study
Sperle, I., Nielsen, S., Gassowski, M., Naneva, Z., Perchemlieva, T., Amato-Gauci, A., An Der Heiden, M., Bremer, V., Golkocheva-Markova, E., Hristov, K., Kaneva, E., Simeonova, Y., Tenev, T., Varleva, T., Duffell, E., Zimmermann, R.
Ability to Monitor National Responses to the HIV Epidemic “Beyond Viral Suppression”: Findings From Six European Countries
Safreed-Harmon, K., Kall, M., Anderson, J., Azzopardi-Muscat, N., Behrens, G.M.N., d'Arminio Monforte, A., Davidovich, U., Noori, T., Lazarus, J.V.
Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
Tavoschi, L., Mason, L., Petriti, U., Bunge, E., Veldhuijzen, I., Duffell, E.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.
Hepatitis C - Annual Epidemiological Report for 2017
In 2017, 31 273 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases, 31 178 cases corresponds to a crude rate of 7.3 cases per 100 000 population.